Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.74 - $1.83 $27,893 - $68,980
37,694 Added 20.88%
218,199 $194,000
Q3 2022

Nov 14, 2022

BUY
$1.51 - $2.88 $3,850 - $7,344
2,550 Added 1.43%
180,505 $283,000
Q2 2022

Aug 12, 2022

BUY
$1.24 - $2.33 $36,746 - $69,047
29,634 Added 19.98%
177,955 $358,000
Q1 2022

May 13, 2022

SELL
$2.0 - $4.9 $20,878 - $51,151
-10,439 Reduced 6.58%
148,321 $346,000
Q4 2021

Feb 11, 2022

BUY
$4.65 - $7.23 $31,150 - $48,433
6,699 Added 4.41%
158,760 $738,000
Q3 2021

Nov 12, 2021

SELL
$7.41 - $10.99 $5,224 - $7,747
-705 Reduced 0.46%
152,061 $1.16 Million
Q2 2021

Aug 13, 2021

BUY
$6.35 - $10.0 $43,732 - $68,870
6,887 Added 4.72%
152,766 $1.48 Million
Q1 2021

May 07, 2021

BUY
$7.03 - $16.51 $2,706 - $6,356
385 Added 0.26%
145,879 $1.21 Million
Q4 2020

Feb 12, 2021

BUY
$5.76 - $11.95 $75,617 - $156,879
13,128 Added 9.92%
145,494 $993,000
Q3 2020

Nov 04, 2020

BUY
$6.17 - $18.82 $154,984 - $472,739
25,119 Added 23.42%
132,366 $1.48 Million
Q2 2020

Aug 12, 2020

BUY
$1.73 - $6.76 $52,066 - $203,448
30,096 Added 39.01%
107,247 $674,000
Q1 2020

May 04, 2020

SELL
$1.57 - $4.76 $1,876 - $5,688
-1,195 Reduced 1.53%
77,151 $142,000
Q4 2019

Feb 05, 2020

SELL
$1.45 - $4.17 $955 - $2,748
-659 Reduced 0.83%
78,346 $265,000
Q3 2019

Nov 08, 2019

BUY
$2.05 - $2.69 $9,483 - $12,443
4,626 Added 6.22%
79,005 $169,000
Q2 2019

Aug 13, 2019

BUY
$2.67 - $4.38 $3,612 - $5,926
1,353 Added 1.85%
74,379 $199,000
Q1 2019

May 06, 2019

BUY
$1.86 - $5.94 $1,953 - $6,237
1,050 Added 1.46%
73,026 $347,000
Q4 2018

Feb 13, 2019

SELL
$2.01 - $4.24 $1,113 - $2,348
-554 Reduced 0.76%
71,976 $173,000
Q3 2018

Nov 09, 2018

BUY
$4.22 - $7.5 $67,076 - $119,212
15,895 Added 28.07%
72,530 $319,000
Q2 2018

Aug 08, 2018

BUY
$4.75 - $8.0 $269,016 - $453,080
56,635 New
56,635 $408,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.